Even MAHA is furious. Trump just used the Defense Production Act to ramp up MORE glyphosate, the weedkiller the WHO says causes cancer, while shielding Bayer from lawsuits.

He framed it as a matter of “national security” and food supply, invoking wartime powers to guarantee the flow of Roundup’s key ingredient into America’s fields.

In 2015 the International Agency for Research on Cancer, part of the WHO classified glyphosate as “probably carcinogenic to humans,” linking it to non-Hodgkin lymphoma.

Since then, Bayer—which bought Monsanto in 2018—has agreed to pay billions to settle tens of thousands of cancer claims tied to Roundup, while continuing to deny the risks.

Now the same chemical at the center of those lawsuits is being elevated to a defense priority. The order doesn’t just boost production, it signals broad federal backing for the companies that make it, potentially insulating them from future accountability.

For a movement built on promises of clean food, healthy kids, and freedom from corporate toxins, this is the breaking point. Protecting pesticide supply chains over public health isn’t “America First.” It’s industry first.

Even within the Make America Healthy Again (MAHA) movement, the same coalition of health-focused voters and activists that once rallied around promises to tackle harmful chemicals, there’s been open outrage.

MAHA organizers are warning that this order could cost Trump their support, accusing the administration of betraying the health-conscious voters who helped make the movement a force in the first place.

This is not just regulatory capture; it’s moral abdication.

It’s unconscionable to enshrine protections for an herbicide with a link to cancer ahead of the very people who live and work in the fields where it’s sprayed. The choice to shield corporate profit and chemical proliferation over community safety exposes a deeper rot in how public health policy is made in this country.